WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010149727) INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND METHOD OF TREATMENT USING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/149727    International Application No.:    PCT/EP2010/058960
Publication Date: 29.12.2010 International Filing Date: 24.06.2010
IPC:
A61K 9/00 (2006.01), A61K 31/40 (2006.01), A61K 31/407 (2006.01), C07D 491/04 (2006.01)
Applicants: N.V. ORGANON [NL/NL]; Kloosterstraat 6 NL-5349 AB Oss (NL) (For All Designated States Except US).
FAASSEN, Werenfridus Adrianus [NL/NL]; (NL) (For US Only).
KEMPERMAN, Gerardus Johannes [NL/NL]; (NL) (For US Only).
VAN LAARHOVEN, Johannes, Antonius, Hendrikus [NL/NL]; (NL) (For US Only)
Inventors: FAASSEN, Werenfridus Adrianus; (NL).
KEMPERMAN, Gerardus Johannes; (NL).
VAN LAARHOVEN, Johannes, Antonius, Hendrikus; (NL)
Agent: VAN WEZENBEEK, P., M., G., F.; P.O. Box 20 NL-5340 BH Oss (NL)
Priority Data:
61/220,027 24.06.2009 US
Title (EN) INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND METHOD OF TREATMENT USING SAME
(FR) FORMULATIONS INJECTABLES CONTENANT DE L'ASÉNAPINE, ET PROCÉDÉ POUR TRAITEMENT FAISANT INTERVENIR CES FORMULATIONS
Abstract: front page image
(EN)The present invention provides a formulation comprising asenapine hemipamoate suspended particles, which formulation can be administered via a Depot provided by an IM injection of the formulation, and which depot does not display a particle-size dependent release rate. The present invention provides also methods of treatment using the same.
(FR)La présente invention concerne une formulation qui comprend des particules d'asénapine hémipamoate en suspension, et qui peut s'administrer par l'intermédiaire d'un dépôt réalisé par une injection intramusculaire de la formulation, le dépôt ne présentant pas un taux de libération qui dépende du calibre particulaire. L'invention concerne également des procédés convenant à un traitement faisant intervenir ces formulations.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)